This is the authors' abstract. We don't add key points for this paper.
Introduction: Ovarian cancer is a malignant tumor with a poor prognosis because it is asymptomatic and often discovered with an accumulation of ascites. Thus, the development of new treatments is needed. Gamma delta T cells have attracted attention as effectors of adoptive cell immunotherapy. To evaluate their safety, the intraperitoneal injection of in vitro-expanded gamma delta T cells with zoledronate was evaluated for the treatment of malignant ascites in ovarian cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: